Globe Life Inc. $GL Shares Acquired by Eads & Heald Wealth Management

Eads & Heald Wealth Management boosted its stake in shares of Globe Life Inc. (NYSE:GL) by 3.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 6,777 shares of the company’s stock after buying an additional 215 shares during the period. Eads & Heald Wealth Management’s holdings in Globe Life were worth $842,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Dimensional Fund Advisors LP increased its position in Globe Life by 9.3% during the first quarter. Dimensional Fund Advisors LP now owns 1,741,131 shares of the company’s stock worth $229,323,000 after purchasing an additional 148,397 shares during the last quarter. Jacobs Levy Equity Management Inc. raised its position in shares of Globe Life by 35.9% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 1,025,984 shares of the company’s stock valued at $135,143,000 after buying an additional 271,253 shares during the period. Nuveen LLC acquired a new position in Globe Life in the first quarter valued at approximately $131,608,000. Swedbank AB lifted its holdings in Globe Life by 77.0% in the first quarter. Swedbank AB now owns 832,000 shares of the company’s stock valued at $109,591,000 after acquiring an additional 362,000 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in Globe Life by 0.4% in the first quarter. Charles Schwab Investment Management Inc. now owns 781,409 shares of the company’s stock worth $102,927,000 after acquiring an additional 3,312 shares during the period. Hedge funds and other institutional investors own 81.61% of the company’s stock.

Globe Life Stock Performance

Shares of GL opened at $137.46 on Monday. The stock has a 50 day moving average price of $140.58 and a 200 day moving average price of $128.56. The company has a market capitalization of $11.13 billion, a price-to-earnings ratio of 10.99 and a beta of 0.55. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.43. Globe Life Inc. has a 52-week low of $100.27 and a 52-week high of $147.83.

Globe Life (NYSE:GL) last announced its earnings results on Wednesday, July 23rd. The company reported $3.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.25 by $0.02. Globe Life had a net margin of 18.11% and a return on equity of 21.24%. The business had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.50 billion. During the same period last year, the firm posted $2.97 earnings per share. The company’s revenue for the quarter was up 2.9% compared to the same quarter last year. Globe Life has set its FY 2025 guidance at 14.250-14.650 EPS. Research analysts predict that Globe Life Inc. will post 13.87 EPS for the current fiscal year.

Globe Life Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, October 3rd will be issued a $0.27 dividend. The ex-dividend date of this dividend is Friday, October 3rd. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life’s payout ratio is presently 8.63%.

Insider Activity

In other news, CEO James Matthew Darden sold 33,270 shares of the firm’s stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $135.59, for a total value of $4,511,079.30. Following the completion of the sale, the chief executive officer directly owned 49,842 shares of the company’s stock, valued at $6,758,076.78. This trade represents a 40.03% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Frank M. Svoboda sold 12,500 shares of Globe Life stock in a transaction that occurred on Thursday, July 31st. The shares were sold at an average price of $141.38, for a total value of $1,767,250.00. Following the completion of the sale, the chief executive officer owned 32,747 shares in the company, valued at approximately $4,629,770.86. This trade represents a 27.63% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 84,722 shares of company stock valued at $11,733,793. Corporate insiders own 1.97% of the company’s stock.

Wall Street Analysts Forecast Growth

GL has been the topic of a number of research analyst reports. Truist Financial started coverage on Globe Life in a research report on Tuesday, July 15th. They issued a “buy” rating and a $150.00 target price on the stock. BMO Capital Markets reiterated a “market perform” rating and set a $149.00 price target (up from $114.00) on shares of Globe Life in a research report on Wednesday, July 30th. Morgan Stanley boosted their price target on shares of Globe Life from $166.00 to $171.00 and gave the company an “overweight” rating in a research note on Monday, August 18th. Cfra Research raised shares of Globe Life to a “moderate buy” rating in a research report on Friday, July 25th. Finally, Weiss Ratings reissued a “buy (b-)” rating on shares of Globe Life in a research note on Saturday, September 27th. One equities research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $152.45.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.